ANKRD26

protein-coding

ankyrin repeat domain containing 26, the group of Ankyrin repeat domain containing

Gene summary

This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Previous symbols:
  • THC2

MANE transcript

NM_014915.3

Inheritance

AD

ClinVar variants

P:3U:2002B:865

Top phenotype

Thrombocytopenia 2

gnomAD constraint

pLI —, LoF o/e 0.58

Max pathogenic AF

—

Genomic locus

chr10:26,973,793-27,100,494

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~126.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

thrombocytopenia 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008555

Submitter: G2P

thrombocytopenia 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008555

Submitter: Ambry Genetics

thrombocytopenia 2DEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0008555

Submitter: ClinGen

ANKRD26 was first reported in relation to autosomal dominant thrombocytopenia 2 in 2011 (Pippucci T, et al., PMID: 21211618). At least 20 unique variants (in the 5’UTR) have been reported in humans. Evidence supporting this gene disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 18 probands in 7 publications (PMIDs: 26175287, 23677566, 30747248, 28109976, 24030261, 21467542, 21211618). Variants in this gene segregated with disease in 38 additional family members. The mechanism of disease is proposed to be gain of function, not haploinsufficiency (PMIDs: 21211618, 24430186). This gene-disease relationship is supported by altered expression and function in patient cells during megakaryopoeisis and proplatelet formation, as well as the rescue of proplatelet formation in patient cells by shRNA knockdown (PMID 24430186). In summary ANKRD26 is definitively associated with autosomal dominant thrombocytopenia 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.

autosomal thrombocytopenia with normal plateletsSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0015679

Submitter: Orphanet

thrombocytopenia 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008555

Submitter: Labcorp Genetics (formerly Invitae)

thrombocytopenia 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0008555

Submitter: PanelApp Australia

acute myeloid leukemiaSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0018874

Submitter: Genomics England PanelApp

Clinical Genomic Database (CGD)

Thrombocytopenia 2AD

Manifestation: Hematologic

Intervention: Hematologic

Rationale: Individuals may have bleeding tendency, and awareness may allow precautions (eg, in surgical situations) and prompt treatment, which may be beneficial

Comments: A variant in ABCD5 was reported as causative

Refs: 10541317; 10521306; 10891439; 20626622; 21211618Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ANKRD26 variants in ClinVar

7 Conditions Cataloged
Inborn genetic diseasesTotal: 2456
not providedTotal: 1284
not specifiedTotal: 239
Thrombocytopenia 2Total: 191
ANKRD26-related disorderTotal: 132
ThrombocytopeniaTotal: 1
Abnormal bleedingTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_014915.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
9
clinvar
677
clinvar
686
missense
1888
clinvar
171
clinvar
14
clinvar
2073
nonsense
1
clinvar
1
clinvar
26
clinvar
2
clinvar
30
start loss
2
clinvar
2
frameshift
1
clinvar
54
clinvar
1
clinvar
56
splice donor/acceptor (+/-2bp)
23
clinvar
23
Total122002851142870

Highest pathogenic variant AF is 0.000017968072

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 52 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_014915.3RefSeqNP_055730.234MANE Select
ENST00000376087.5EnsemblENSP00000365255.434MANE Select
NM_001256053.2RefSeqNP_001242982.134Standard
ENST00000436985.7EnsemblENSP00000405112.334Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • negative regulation of fat cell differentiation

Molecular Function

  • protein binding

Cellular Component

  • centrosome

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000376087
Coding exons
34
Length
108579
Individuals with no LoFs
124625
Homozygous LoFs
0
Heterozygous LoFs
180
Defined
124805
p
0.000721
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.3968558231.040.000038711402
Missense (PolyPhen)147160.190.917642511
Synonymous0.1612912950.9880.00001452917
Loss of Function3.685390.90.5830.000004281221

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000780.00078rare
Latino/Admixed American0.00100.0010notable
Ashkenazi Jewish0.000200.00020rare
East Asian0.000450.00044rare
Finnish0.00140.0014notable
European (Non-Finnish)0.000600.00060rare
South Asian0.000630.00062rare
Other0.00100.00099rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Acts as a regulator of adipogenesis. Involved in the regulation of the feeding behavior. {ECO:0000250|UniProtKB:Q811D2}.;
Disease
DISEASE: Thrombocytopenia 2 (THC2) [MIM:188000]: Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. {ECO:0000269|PubMed:21211618}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.102

Intolerance Scores

LoFtool
0.985
RVIS EVS
2.15
RVIS percentile EVS
97.98

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.287

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.